Virasal
Product Images NDC 42783-312

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Virasal (NDC 42783-312). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Elorac, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Virasal Bottle Label 26sep2014.jpg (Virasal Bottle Label 26sep2014)

Label for Virasal wart remover containing 27.5% salicylic acid in an antiviral film-forming vehicle. The product comes in a 1/3 fl. oz. (10 mL) container. It is manufactured by Elorac, Inc., Vernon Hills, IL, and is intended for dermatological use only, not for use in eyes. The label includes usage instructions and notes the product is Rx only.*

FDA Label Image

Virasal Carton Label 26sep2014b.jpg (Virasal Carton Label 26sep2014b)

Packaging label for Virasal (27.5% Salicylic Acid) Antiviral Film-Forming Vehicle, a wart remover. The label indicates a 1/3 fl. oz. (10 mL) bottle, for dermatological use only, not for use in eyes, and prescription only. It lists ingredients, usage instructions, warnings, storage conditions, and manufacturer information for Elorac, Inc.*

FDA Label Image

Structure.jpg (Structure)

Chemical structure diagram showing a benzene ring with carboxyl (COOH) and hydroxyl (OH) groups, representing the active ingredient associated with Virasal by Elorac, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.